Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Zealand Pharma
  4. Zealand Pharma — Maj 2022

Zealand Pharma — Maj 2022

Planlagt Fastgjort Låst Flyttet Zealand Pharma
170 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • exitnuE Offline
    exitnuE Offline
    exitnu
    wrote on sidst redigeret af
    #21

    ZEALAND PHARMA (Q1) kl. 15.00 🙂

    1 Reply Last reply
    0
    • exitnuE Offline
      exitnuE Offline
      exitnu
      wrote on sidst redigeret af
      #22

      "Zealand Pharma venter i 2022 nettodriftsomkostninger i niveauet 1000 mio. kr. samt et salg af kommercielle produkter på 115 mio. kr. Begge tal indebærer en usikkerhed på +/- 10 pct."

      1 Reply Last reply
      0
      • exitnuE Offline
        exitnuE Offline
        exitnu
        wrote on sidst redigeret af
        #23

        Zealand Pharma Provides Update on Refocused Strategy Prioritizing Research and Development

        • Revenue: DKK 15.1 million / USD 2.3 million (DKK 5.7 million / USD 0.9 million in the first three months of 2021).
        • Net operating expenses: DKK -314.2 million / USD -46.9 million (DKK -266.7 million / USD -42.0 million in the first three months of 2021).

        1 Reply Last reply
        0
        • exitnuE Offline
          exitnuE Offline
          exitnu
          wrote on sidst redigeret af
          #24

          • Net operating result: DKK -302.0 million / USD -45.1 million (DKK -261.1 million / USD -41.2 million in the first three months of 2021).
          • Net financial items: DKK 133.0 million / USD 19.9 million (DKK 19.8 million / USD 3.1 million in the first three months of 2021).

          1 Reply Last reply
          0
          • exitnuE Offline
            exitnuE Offline
            exitnu
            wrote on sidst redigeret af
            #25

            • Net result from Discontinued Operations Related to Restructuring: DKK -41.8 million / USD -6.2 million (DKK 0.0 million / USD 0.0 million in the first three months of 2021).
            • Cash, cash equivalents, and marketable securities: DKK 1,123.2 million / USD 167.6 million as of March 31, 2022 (March 31, 2021: DKK 1,604.1 million / USD 252.9 million).

            1 Reply Last reply
            0
            • exitnuE Offline
              exitnuE Offline
              exitnu
              wrote on sidst redigeret af
              #26

              Link Preview Image
              404 Page

              GlobeNewswire specializes in the distribution and delivery of press releases, financial disclosures and multimedia content to the media and general public.

              favicon

              (www.globenewswire.com)

              1 Reply Last reply
              0
              • exitnuE Offline
                exitnuE Offline
                exitnu
                wrote on sidst redigeret af
                #27

                Financial guidance for 2022
                On March 30, 2022 Zealand updated the guidance for net product revenue from the sales of commercial products to be DKK 115 million +/- 10%. This was a decrease of 120 million Danish kroner from the guidance issued on March 10, 2022. Combined sales of V-Go and Zegalogue in Q1 were 39.2 million Danish kroner and in line with the updated guidance.

                1 Reply Last reply
                0
                • exitnuE Offline
                  exitnuE Offline
                  exitnu
                  wrote on sidst redigeret af
                  #28

                  Net operating expenses in 2022 are expected to be DKK 1,000 million +/-10%. This is unchanged from our updated guidance issued on March 30, 2022 and is a decrease of DKK 200 million from the guidance issued on March 10, 2022.

                  1 Reply Last reply
                  0
                  • exitnuE Offline
                    exitnuE Offline
                    exitnu
                    wrote on sidst redigeret af
                    #29

                    Ingen udmelding mht. de forventede indtægter i hele 2022.

                    1 Reply Last reply
                    0
                    • SvingtraderenS Offline
                      SvingtraderenS Offline
                      Svingtraderen
                      wrote on sidst redigeret af
                      #30

                      tak, chef

                      1 Reply Last reply
                      0
                      • SvingtraderenS Offline
                        SvingtraderenS Offline
                        Svingtraderen
                        wrote on sidst redigeret af
                        #31

                        🙂

                        1 Reply Last reply
                        0
                        • SvingtraderenS Offline
                          SvingtraderenS Offline
                          Svingtraderen
                          wrote on sidst redigeret af
                          #32

                          susp guidance for omsætning i 2022 -

                          1 Reply Last reply
                          0
                          • Helge_LarsenPI-redaktørH Offline
                            Helge_LarsenPI-redaktørH Offline
                            Helge_LarsenPI-redaktør
                            wrote on sidst redigeret af
                            #33

                            Q&A fredag d. 20. kl 15. Stil gerne spørgsmål til Adam allerede nu.

                            1 Reply Last reply
                            0
                            • Helge_LarsenPI-redaktørH Offline
                              Helge_LarsenPI-redaktørH Offline
                              Helge_LarsenPI-redaktør
                              wrote on sidst redigeret af
                              #34

                              Zealand Pharma Q1: Stor omsktrukturering - mere fokus på RnD https://www.proinvestor.com/investornyt/823603/zealand-pharma-q1-stor-omsktrukturering-mere-fokus-pa-rnd

                              1 Reply Last reply
                              0
                              • exitnuE Offline
                                exitnuE Offline
                                exitnu
                                wrote on sidst redigeret af
                                #35

                                Zealand Pharma A/S (ZEAL) CEO Adam Steensberg on Q1 2022 Earnings Call Transcript:

                                Access to this page has been denied

                                px-captcha

                                favicon

                                (seekingalpha.com)

                                1 Reply Last reply
                                0
                                • exitnuE Offline
                                  exitnuE Offline
                                  exitnu
                                  wrote on sidst redigeret af
                                  #36
                                  • Matt Dallas - SVP and CFO
                                  • Adam Steensberg - President and CEO
                                  • Conference Call Participants
                                  • Thomas Bowers - Danske Bank
                                  • Joseph Stringer - Needham
                                  • Lucy Codrington - Jefferies
                                  1 Reply Last reply
                                  0
                                  • exitnuE Offline
                                    exitnuE Offline
                                    exitnu
                                    wrote on sidst redigeret af
                                    #37
                                    • Company Participants
                                    1 Reply Last reply
                                    0
                                    • exitnuE Offline
                                      exitnuE Offline
                                      exitnu
                                      wrote on sidst redigeret af
                                      #38

                                      Needham Maintains Buy on Zealand Pharma, Lowers Price Target to $32

                                      Needham analyst Joseph Stringer maintains Zealand Pharma with a Buy and lowers the price target from $42 to $32.

                                      1 Reply Last reply
                                      0
                                      • exitnuE Offline
                                        exitnuE Offline
                                        exitnu
                                        wrote on sidst redigeret af
                                        #39

                                        Svarer ca. til kurs 229. Hvilket svarer til +219% oppe i forhold til gårsdagens lukkekurs i kurs 73,75 🙂

                                        1 Reply Last reply
                                        0
                                        • exitnuE Offline
                                          exitnuE Offline
                                          exitnu
                                          wrote on sidst redigeret af
                                          #40

                                          Og Joseph Stringer var igennem på CC igår ...
                                          🙂

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper